Enzyme Corporation
Latest round
- Seed
Last raised
- Oct 2017
Total raised
- $1.9M
Investors
- 5
About Enzyme Corporation
Founded in 2015, Enzyme Corporation specializes in developing a comprehensive Electronic Quality Management System (eQMS). The firm has completed a total of 2 deals, indicating robust interest and investment in its offerings. The company was co-founded by Jacob Graham and Jared Seehafer, who previously founded other companies in the tech space.Enzyme offers a comprehensive Electronic Quality Management System (eQMS) tailored specifically for the life sciences sector, including medical device, digital health, and biopharma companies. The core product is designed to streamline and enhance quality management processes, covering the entire product lifecycle from premarket to postmarket, making it suitable for organizations ranging from startups to large enterprises. Key functionalities include document control, change control, training management, risk management, and compliance solutions, all developed with input from quality and regulatory professionals. Enzyme's eQMS is characterized by its flexibility and scalability, allowing users to integrate it with existing tools and import data easily, thus fostering a more efficient workflow.Enzyme's business model centers around subscription-based transactions, where clients pay for access to its eQMS platform and associated functionalities. The revenue is generated primarily through annual subscriptions that provide continuous access to the software, ensuring updates and customer support throughout the contract term. The firm also offers consulting services to optimize quality management practices, further enhancing customer engagement and satisfaction. The company aims to introduce new features within its eQMS platform, designed to be launched by the end of 2023. Additionally, Enzyme is targeting expansion into the Asian market, specifically South Korea and Japan, with plans to establish a presence there by 2024.
Who invested in Enzyme Corporation
5 investors across 1 round
See all investors in Enzyme Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 10, 2017
Amount
$1.9M
Investors
Questions about Enzyme Corporation
Who invested in Enzyme Corporation?
Enzyme Corporation has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Enzyme Corporation raised?
Enzyme Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Enzyme Corporation last raise money?
Enzyme Corporation's most recent round on record is a Seed, in Oct 2017.
What does Enzyme Corporation do?
Founded in 2015, Enzyme Corporation specializes in developing a comprehensive Electronic Quality Management System (eQMS).
Where is Enzyme Corporation headquartered?
Enzyme Corporation is headquartered in San Francisco, US.
Which VCs invest in companies like Enzyme Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at Enzyme Corporation's stage. Their profiles are linked below.
VCs backing software startups at Seed
Raising like Enzyme Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.